Tracking Retinal Ganglion Cell Soma Loss in Glaucoma Reveals Progression Over Months and Years
Investigative Ophthalmology & Visual Science · 17.11.2026 · 67 (13) · 33
DOI: 10.1167/iovs.67.13.33 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 17.11.2026. Verfasst von Matthew Keller und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Optometry, Indiana University, Bloomington, Indiana, United States. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Tomography, Optical Coherence, Glaucoma, Open-Angle. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Adaptive optics optical coherence tomography (AO-OCT) has the potential to transform how glaucoma progression is assessed by directly measuring loss of ganglion cells over time. Here, we used AO-OCT to measure ganglion cell layer (GCL) soma loss in glaucoma subjects over time intervals as short as 3 months.
Methods
We recruited six glaucoma subjects with moderate-to-severe primary open-angle, low-tension, or pigmentary glaucoma (63.2 ± 3.4 years, mean ± SD) and two age-similar controls. AO-OCT volumes traversing arcuate defects were acquired at both multi-year (2-8 years, 3 subjects) and sub-year (3-12 months, all subjects) intervals. GCL soma count and layer thickness were measured in four to six subregions per subject to determine annualized loss rate (%/yr) across the defect. Clinical OCT thickness measurements were also acquired.
Results
Annualized GCL soma loss rates in the 3 multi-year subjects were -1.8, -10.3, and -5.4%/yr, exceeding aging rates in controls by approximately 5 to 28 times. Loss was detectable in all subjects at 3- to 6-month intervals (-0.35 to -7.8%/yr). Soma density loss and GCL thinning rates were weakly correlated when the follow-up interval was under 1 year (glaucomatous: r = 0.32; healthy: r = 0.34). Variation in loss rate across the arcuate defect was significant over sub-year intervals, with the highest rates near the defect edge. Clinical OCT measurements did not exceed progression thresholds in any subject over sub-year intervals.
Conclusions
AO-OCT can detect individual glaucomatous GCL soma loss over intervals as short as 3 months, at rates clearly distinguishable from age-related decline. Glaucomatous rates were subclinical by OCT and peaked within the arcuate defect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Optometry, Indiana University, Bloomington, Indiana, United States.
Zitieren
APA
Keller, M., Liu, Y., Bernucci, M., Bowles-Johnson, K., Ji, Q., Crowell, J. A., Kurokawa, K., Swanson, W. H., King, B. J., & Miller, D. T. (2026). Tracking Retinal Ganglion Cell Soma Loss in Glaucoma Reveals Progression Over Months and Years. Investigative Ophthalmology & Visual Science, 67(13), 33. https://doi.org/10.1167/iovs.67.13.33
Vancouver
Keller M, Liu Y, Bernucci M, Bowles-Johnson K, Ji Q, Crowell JA, et al. Tracking Retinal Ganglion Cell Soma Loss in Glaucoma Reveals Progression Over Months and Years. Investigative Ophthalmology & Visual Science. 2026;67(13):33. doi:10.1167/iovs.67.13.33
BibTeX
@article{Keller2026,
author = {Keller, Matthew and Liu, Yan and Bernucci, Marcel and Bowles-Johnson, Kristen and Ji, Qiuzhi and Crowell, James A and Kurokawa, Kazuhiro and Swanson, William H and King, Brett J and Miller, Donald T},
title = {Tracking Retinal Ganglion Cell Soma Loss in Glaucoma Reveals Progression Over Months and Years},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
volume = {67},
number = {13},
pages = {33},
doi = {10.1167/iovs.67.13.33}
}
EUVIMED